e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Epidemiology of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Measurement of COPD severity: further validation of a survey-based instrument
M. Eisner, P. Katz, C. Iribarren, E. Yelin, P. Blanc (San Francisco, CA, Oakland, CA, United States Of America)
Source:
Annual Congress 2007 - Epidemiology of COPD
Session:
Epidemiology of COPD
Session type:
Thematic Poster Session
Number:
3681
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Eisner, P. Katz, C. Iribarren, E. Yelin, P. Blanc (San Francisco, CA, Oakland, CA, United States Of America). Measurement of COPD severity: further validation of a survey-based instrument. Eur Respir J 2007; 30: Suppl. 51, 3681
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Measurement of COPD severity: development and validation of a survey-based instrument
Source: Eur Respir J 2003; 22: Suppl. 45, 353s
Year: 2003
Detection and evaluation severity of COPD by ipag questionnaires: evaluation of ipag questionnaires in COPD in Japan
Source: Annual Congress 2009 - Diagnostic strategies in primary respiratory care
Year: 2009
Development and first validation of the COPD Assessment Test
Source: Eur Respir J 2009; 34: 648
Year: 2009
Challenges in classification of asthma severity from prescription data: a pilot study
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009
Derivation and validation of the subscales of the severe asthma questionnaire
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021
Linguistic validation of the Clinical COPD Questionnaire (CCQ) for use in international studies
Source: Eur Respir J 2005; 26: Suppl. 49, 513s
Year: 2005
External multicentric validation of a COPD detection questionnaire
Source: Annual Congress 2012 - Methodology in epidemiologic research
Year: 2012
Validity and reliability of the symptom domain of the clinical COPD questionnaire (CCQ)
Source: Eur Respir J 2006; 28: Suppl. 50, 807s
Year: 2006
Development and validation of a new comorbidity index for COPD
Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD
Year: 2011
Longitudinal assessment in COPD patients: multidimensional variability and outcomes
Source: Eur Respir J 2014; 43: 745-753
Year: 2014
Disease awareness in COPD: Analyses of clinical parameters and patient-reported outcome from the SAT study
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020
Development and pilot testing of a new 7-item cough severity patient reported outcome measure
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008
Self-reported COPD: spirometric validation in a resource limited setting
Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD
Year: 2008
Validation of a diagnosis-agnostic symptom questionnaire for asthma and/or COPD
Source: ERJ Open Res, 7 (1) 00828-2020; 10.1183/23120541.00828-2020
Year: 2021
Psychometric validation of an electronic diary to measure symptoms of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 514s
Year: 2005
Validity of an automated telephonic system to assess exacerbation rates in prospective clinical COPD studies
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011
Development and validation of an innovative self-administered computerized (SAC) version of baseline/transition dyspnea index (BDI/TDI) for evaluating breathlessness in patients with COPD: The BLAZE study
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
Asthma Control Questionnaire in children: validation, measurement properties, interpretation
Source: Eur Respir J 2010; 36: 1410-1416
Year: 2010
GOLD assessment of COPD patients: Impact of symptoms assessment choice
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012
Validity of the Brief physical activity assessment tool for clinical use in COPD
Source: International Congress 2017 – Assessing pulmonary and extra-pulmonary function in chronic disease
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept